A recent study said that flood irrigation used to cultivate rice in India leads to longer exposure to contaminated water and soil, increasing the rate of arsenic absorption
Coronavirus Updates: Delhi reports 11 deaths today, lowest in over a month; 1,076 test positive in past 24 hrs
Coronavirus Updates: The positivity rate in Delhi stood at 6.4 percent while the recovery rate was nearly 90 percent on Wednesday, a state health department bulletin said
Decoy ACE2 proteins can be used to prevent COVID-19 causing virus from entering host cells, claims US study
Viruses are intracellular parasites, meaning they need the machinery of our body cells to make copies of themselves.
The Mumbai-based firm is also ramping up manufacturing of drugs required to treat COVID-19, like Lopinavir-Ritonavir and Hydroxychloroquine
A test against bacterial pneumonia resulted in zero deaths in a group who got photodynamic therapy while 60% of the control group participants died
According to a study, COVID-19 patients may have a productive cough as a presenting symptom at the onset of the infection or develop it at a later stage
Zydus Cadila's COVID-19 vaccine passes Phase I safety trials; Phase II to test efficiency begins 6 August
The vaccine candidate was found 'very safe' after volunteers in the Phase I trial were examined at 24 hours and 7 days after the shot.
Lupin launches antiviral drug Favipiravir under the name Covihalt to treat mild to moderate COVID-19 infection
The Covihalt tablet will be available in 200 mg tablets in a strip of 10 and will cost Rs 49 per tablet in India.
Emerging landscape of COVID-19 vaccines in India, as of 5 Aug: Bharat Bio, Zydus candidates move to Phase 2 after clearing test of safety
Over a dozen Indian companies are in partnership with other firms and institutes to bring a preventive vaccine into global markets by 2021.
With a major chunk of CSR funding having gone towards the PM-CARES Fund, there are few resources left with corporate organisations to fund new initiatives
Sunpharma launches Favipiravir tablet Fluguard to treat mild to moderate COVID-19 infections at Rs 35 per pill
Favipiravir is an antiviral drug that was originally made to treat influenza in Japan under the brand name Avigan.
The doodle reinforces that wearing masks can save lives, in the midst of a resurgence of COVID-19 cases across the globe.
Treating severe COVID-19 might require an immunological reset, with drugs that could, in theory, restore the balance in the body.
Coronavirus Updates: As many as 2,326 patients recovered during the day, the state health department said, taking the total number of recoveries to over 2.99 lakh
Doomscrolling is the habit of scrolling non-stop to consume information on dangers around you, such as, currently, the COVID-19 pandemic
SARS-CoV-2 strains show little variability, COVID-19 vaccine could be effective against all, finds study
Published in journal 'Frontiers in Microbiology', the study drew from the analysis of 48,635 novel coronavirus genomes, which were isolated in labs all over the world
Pradhan, who had met Amit Shah last week, is the second Union minister after the home minister to have tested positive for coronavirus
The US President claimed that the nation has tested 60 million for coronavirus and added that no other country came close to that figure (edited)
The future of our food safety, public health, and financial resilience could depend on It.
From nurses and doctors to contract tracers and volunteers, women are disproportionately represented on the front lines of health care delivery, study finds.